Skip to main content
SteadySharesSteadySharesSteadyStShares
The market
MarketsDiscover
Follow the money
Super InvestorsPolitician TradesCrypto Desk
Yours
My WealthNews
Settings Sign in to save your work
Closed
SteadySharesMarketsDiscoverSuper InvestorsMy WealthPoliticiansCryptoNews
DiscoverREL.L
TechnologyLSEGBP

RELX plc

£0012345678900123456789.0012345678900123456789+4.8%
52w low (est.) £21.24£31.66 52w high (est.)
Market data · updated 1h ago
Peers
Market data
Market cap
£56.85B
52w range
£19.91 - £39.76
Beta
0.26
Sector
Technology
Valuation
P/E ratio
21.6x
DCF fair value
£38.00
Margin of safety
+48.0%
Forward P/E
15.4x
PEG ratio
1.29
Dividend yield
2.79%
Quality & efficiency
Moat score
84/100
Return on equity
70.5%
Profit margin
21.5%
Debt / equity
3.04
Growth & analysts
Revenue growth
+1.2%
Analyst target
£34.08
Target upside
+32.7%
Analysts
16
Run the 10-point checklist before you buy How these numbers are made

About RELX plc

RELX PLC, together with its subsidiaries, provides information-based analytics and decision tools for professional and business customers in North America, Europe, and internationally. It operates through four segments: Risk; Scientific, Technical & Medical; Legal; and Exhibitions. The Risk segment offers information-based analytics and decision tools that combine public and industry specific content with technology and algorithms to assist clients in evaluating and predicting risk, as well as a portfolio of commercial healthcare products. Its Scientific, Technical & Medical segment provides scientific and medical information and data sets for science and healthcare. The Legal segment provides legal, regulatory, and business information and analytics. Its Exhibitions segment combines digital tools and data to help customers connect in-person and online, discover new markets, source products, generate leads, and transact. The company was formerly known as Reed Elsevier PLC and changed its name to RELX PLC in July 2015. RELX PLC was incorporated in 1903 and is headquartered in London, the United Kingdom.

Valuation

ValueGrowthProfitHealthIncome53QUALITY
Overall Rating
70
Strong Buy
Strong Buy
Moat Score84
DCF Intrinsic Value
£38.00+48.0% upside

Moat, DCF and rating computed by our valuation engine (ported from the original Python model).

Fundamentals

Market Cap
£56.85B
P/E Ratio
21.6
Dividend Yield
2.79%
Revenue Growth
+1.2%
Profit Margin
21.5%
ROE
70.5%
Debt / Equity
3.04
Beta
0.26
High GrowthMomentum
vs Technology sector:P/E 22 vs 53 · cheaperMoat 84 vs 9Yield 2.79% vs 0.1%

Statistics

Similar Stocks · Technology

MSFT78
$441.20+0.8%
AAPL74
$228.50+1.2%
AVGO74
$1,700.00+1.4%
NVDA71
$124.30+3.4%

Latest News · REL.L